Sage Therapeutics (SAGE) PT Lowered to $35 at RBC Capital
Tweet
Share
E-mailGet Alerts SAGE Hot Sheet
Price: $32.30 --0%
Rating Summary:
14 Buy, 12 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 10 | New: 9
Rating Summary:
14 Buy, 12 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 10 | New: 9
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams lowered the price target on Sage Therapeutics (NASDAQ: SAGE) to $35.00 (from $37.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- Micron Technology (MU) PT Lowered to $64 at Needham & Company
- Cousins Properties (CUZ) PT Lowered to $33 at Wells Fargo
- Douglas Emmett Inc. (DEI) PT Lowered to $28 at Wells Fargo
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
